Retrograde sensory ganglionectomy for control of intractable pain

逆行感觉神经节切除术控制顽固性疼痛

基本信息

项目摘要

Our earlier studies indicated that several neurotoxins could be retrogradely transported to their parental sensory neurons when intraneurally injected into the peripheral nerve. Consequently, sensory neurons having taken up the toxin underwent degeneration. Utilizing this phenomenon, we initiated a study in which suitable neurotoxins when injected into the nerve may selectively gangliotomize the particular groups of sensory cells in the dorsal root ganglia or trigeminal ganglia and thus serve as a way of controlling pain.Among more than several neurotoxins studied, we found doxorubicin(Adriamycin, ADM) is in particular useful for this purpose since ADM has its proper autofluorescence which enabled us to localize the route and destination of ADM when injected. Within 12 hrs after intraneural injection of ADM into the cat's trigeminal nerve branches, ADM was demonstrated in the trigeminal ganglion cells in a topographically organized manner. Within several days, these neurons having take … More n up ADM underwent selective degeneration. The primary afferents entering into the brainstem trigeminal complex could be traced upt to the spinal trigeminal nucleus by the Fink-Helmer method. The short latency sensory evoked potential (SSEP) of the trigeminal nerve disclosed the abolishment of the entire waveforms 24-48 hrs after the injection of ADM into the corresponding nerve. The SSEP never recovered when once lost.Following these basic data, we initiated the ADM ganglionectomy to three selected patients with intractable neuralgic pain syndrome. Two with postherpetic neuralgia and the third with failed trigeminal neuralgia to a variety of attempts. These patients responded favorably to ADM ganglionectomy. One, complete abolishment of pain, the second, 50 % and the third 70 % relief. Some remaining pain after ADM ganglionectomy in two patients was in part explained by the wider extent of pain which was not totally denervaied by a single injection. This novel method of pain control may be utilized for neuralgic pain syndromes of deafferentation in nature such as postherpetic neuralgia, phantom limb pain, and pain due to cancer invasion into the nerves. Less
我们早期的研究表明,当神经内注射到周围神经时,几种神经毒素可以逆行转运到它们的亲代感觉神经元。因此,吸收了毒素的感觉神经元发生变性。利用这一现象,我们开始了一项研究,在这项研究中,当将合适的神经毒素注射到神经中时,可以选择性地切断背根神经节或三叉神经节中的特定感觉细胞群,从而作为控制疼痛的一种方式。阿霉素(Adriamycin,ADM)对于该目的特别有用,因为ADM具有其适当的自体荧光,这使得我们能够在注射时定位ADM的途径和目的地。在猫三叉神经分支神经内注射ADM后12小时内,ADM在三叉神经节细胞中以拓扑学组织化的方式被证明。几天之内,这些神经元 ...更多信息 ADM组选择性变性。用Fink-Helmer法可将进入脑干三叉神经复合体的初级传入纤维追踪至三叉神经脊束核。三叉神经短潜伏期感觉诱发电位(SSEP)显示ADM注入后24-48小时,三叉神经短潜伏期感觉诱发电位(SSEP)全部消失。根据这些基本资料,我们选择了三位患有顽固性神经痛综合征的病人,进行ADM神经节切除术。两个带状疱疹后神经痛和三叉神经痛失败的第三种尝试。这些患者对ADM神经节切除术反应良好。第一种是完全消除疼痛,第二种是减轻50%,第三种是减轻70%.两名患者接受ADM神经节切除术后仍存在一些疼痛,部分原因是疼痛程度更广,单次注射并未完全消除神经支配。这种新的疼痛控制方法可用于神经痛性疼痛综合征的传入神经阻滞的性质,如带状疱疹后神经痛,幻肢痛,疼痛由于癌症侵入神经。少

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
S.Kato,T.Ohtsuki,T.Yamamoto: "Retrograde axoplasmic transport of Adriamycin for neuralgic pain." J applied Neurophysiology. (1990)
S.Kato、T.Ohtsuki、T.Yamamoto:“阿霉素的逆行轴浆转运治疗神经痛。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kato, S., Yamamoto, T., Iwasaki, Y.: "Retrograde axoplasmic transport of Adriamycin (Neurosurgical Forum)." J. Neurosurg. 70:819-820, 1989.
Kato, S.、Yamamoto, T.、Iwasaki, Y.:“阿霉素的逆行轴浆运输(神经外科论坛)。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Yamamoto: "Retrograde axoplasmic transport of neurotoxins,in Methods in Neurosciences.Vol 3" Academic Press,USA, inpress (1990)
T.Yamamoto:“神经毒素的逆行轴浆运输,神经科学方法。第 3 卷”学术出版社,美国,inpress (1990)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kato, S., Yamamoto, T., Iwasaki, Y., Niizuma, H., Nakamura, T., Suzuki, J.: "Experimental retrograde sensory ganglionectomy." J Neurosurg. 69:760-765, 1988.
Kato, S.、Yamamoto, T.、Iwasaki, Y.、Niizuma, H.、Nakamura, T.、Suzuki, J.:“实验性逆行感觉神经节切除术。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamamoto, T.: "Retrograde axoplasmic transport of neurotoxins." Methods in Neurosciences ed. by R. Conn, Academic Press, Orlando (vol 3).
Yamamoto, T.:“神经毒素的逆行轴浆运输。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMAMOTO Teiji其他文献

YAMAMOTO Teiji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMAMOTO Teiji', 18)}}的其他基金

Serum anti-phospholipid antibodies in patients with multiple sclerosis
多发性硬化症患者血清抗磷脂抗体
  • 批准号:
    05670566
  • 财政年份:
    1993
  • 资助金额:
    $ 6.21万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Studies of specific treatment strategies utilizing axoplasmic transpot in motor neuron diseases.
利用轴浆转运治疗运动神经元疾病的具体治疗策略的研究。
  • 批准号:
    63480214
  • 财政年份:
    1988
  • 资助金额:
    $ 6.21万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Pathogenesis and Treatment Strategies of Motor Neuron Diseases as Functions of Retrograde Axoplasmic Transport
逆行轴浆运输功能的运动神经元疾病的发病机制和治疗策略
  • 批准号:
    60480219
  • 财政年份:
    1985
  • 资助金额:
    $ 6.21万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
  • 批准号:
    82370981
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目

相似海外基金

Brain Mechanisms of Chronic Low-Back Pain: Specificity and Effects of Aging and Sex
慢性腰痛的脑机制:衰老和性别的特异性和影响
  • 批准号:
    10657958
  • 财政年份:
    2023
  • 资助金额:
    $ 6.21万
  • 项目类别:
The role of limbic structures, memory and emotion in chronic neuropathic pain
边缘系统、记忆和情绪在慢性神经病理性疼痛中的作用
  • 批准号:
    493861
  • 财政年份:
    2023
  • 资助金额:
    $ 6.21万
  • 项目类别:
    Operating Grants
Functional and histological changes to peripheral innervation following spinal cord stimulation in patients with painful diabetic neuropathy
疼痛性糖尿病神经病变患者脊髓刺激后周围神经支配的功能和组织学变化
  • 批准号:
    10837475
  • 财政年份:
    2023
  • 资助金额:
    $ 6.21万
  • 项目类别:
Development of oral KCC2 enhancer drug for treatment of painful diabetic neuropathy
开发用于治疗疼痛性糖尿病神经病变的口服 KCC2 增强剂药物
  • 批准号:
    10699218
  • 财政年份:
    2023
  • 资助金额:
    $ 6.21万
  • 项目类别:
An Examination of Concomitant Non-Medical Use of Gabapentin and Opioids.
加巴喷丁和阿片类药物同时非医疗用途的检查。
  • 批准号:
    10510127
  • 财政年份:
    2022
  • 资助金额:
    $ 6.21万
  • 项目类别:
Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions (The MSK-PELVIC Study)
女性慢性盆腔重叠疼痛的肌肉骨骼和盆底健康(MSK-PELVIC 研究)
  • 批准号:
    10527205
  • 财政年份:
    2022
  • 资助金额:
    $ 6.21万
  • 项目类别:
Visualizing trigeminal neuralgia at 7 Tesla: Advancing etiological understanding and improving future clinical imaging protocols
7 特斯拉可视化三叉神经痛:促进病因学理解并改进未来的临床成像方案
  • 批准号:
    10667246
  • 财政年份:
    2022
  • 资助金额:
    $ 6.21万
  • 项目类别:
Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions (The MSK-PELVIC Study)
女性慢性盆腔重叠疼痛的肌肉骨骼和盆底健康(MSK-PELVIC 研究)
  • 批准号:
    10705656
  • 财政年份:
    2022
  • 资助金额:
    $ 6.21万
  • 项目类别:
Mapping the human DRG and spinal cord functional genome at cellular and spatial resolution
以细胞和空间分辨率绘制人类 DRG 和脊髓功能基因组图谱
  • 批准号:
    10593658
  • 财政年份:
    2022
  • 资助金额:
    $ 6.21万
  • 项目类别:
Mapping the human DRG and spinal cord functional genome at cellular and spatial resolution
以细胞和空间分辨率绘制人类 DRG 和脊髓功能基因组图谱
  • 批准号:
    10707548
  • 财政年份:
    2022
  • 资助金额:
    $ 6.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了